PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinoma
Emerging immunotherapies quest for better patient stratification in cancer treatment decisions. Moderate response rates of PD-1 inhibition in gastric and esophagogastric junction cancers urge for meaningful human model systems that allow for investigating immune responses ex vivo. Here, the standard...
Main Authors: | Marlon Hußtegge, Ngoc Anh Hoang, Jakob Rebstock, Astrid Monecke, Ines Gockel, Arved Weimann, Guido Schumacher, Ingo Bechmann, Florian Lordick, Sonja Kallendrusch, Justus Körfer |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2021.1960729 |
Similar Items
-
FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo
by: Luzie Brückner, et al.
Published: (2021-02-01) -
Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View
by: Justus Körfer, et al.
Published: (2021-10-01) -
Mechanisms of co-stimulatory and inhibitory receptors in human cancer-specific cytotoxic T cells
by: Bin Abd Hamid, M
Published: (2019) -
Remodelling of the immune landscape and its effect of tumour immunity in a model of IFNy-insensitive murine melanoma
by: Lau, VWC
Published: (2023) -
Defining the dynamic relationship between interferon-gamma and CD8+T cell dysfunction in melanoma
by: Mazet, JMM
Published: (2022)